propidium has been researched along with Cystic Fibrosis of Pancreas in 8 studies
Propidium: Quaternary ammonium analog of ethidium; an intercalating dye with a specific affinity to certain forms of DNA and, used as diiodide, to separate them in density gradients; also forms fluorescent complexes with cholinesterase which it inhibits.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Propidium monoazide (PMA)-pretreatment has increasingly been applied to remove the bias from dead or damaged cell artefacts, which could impact the microbiota analysis by high-throughput sequencing." | 5.43 | Effects of Propidium Monoazide (PMA) Treatment on Mycobiome and Bacteriome Analysis of Cystic Fibrosis Airways during Exacerbation. ( Audebert, C; Delhaes, L; Deschaght, P; Loywick, A; Merlin, S; Nguyen, LD; Van Daele, S; Vaneechoutte, M; Viscogliosi, E, 2016) |
| "To evaluate the antibacterial and antibiofilm mechanisms of usnic acid (USN) against methicillin-resistant Staphylococcus aureus from cystic fibrosis patients." | 3.83 | Evaluation of antibacterial and antibiofilm mechanisms by usnic acid against methicillin-resistant Staphylococcus aureus. ( Angelucci, S; Barone, L; Crocetta, V; Di Bonaventura, G; Di Giulio, A; Di Giuseppe, F; Di Ilio, C; Pompilio, A; Pomponio, S; Riviello, A; Sulpizio, M, 2016) |
| " Terminal restriction fragment length polymorphism profiling of cystic fibrosis sputum samples was combined with propidium monoazide (PMA) photo-induced cross-linking." | 3.74 | Assessing the diagnostic importance of nonviable bacterial cells in respiratory infections. ( Bruce, KD; Carroll, MP; Daniels, T; Koller, G; Rogers, GB; Stressmann, FA, 2008) |
| "Propidium monoazide (PMA)-pretreatment has increasingly been applied to remove the bias from dead or damaged cell artefacts, which could impact the microbiota analysis by high-throughput sequencing." | 1.43 | Effects of Propidium Monoazide (PMA) Treatment on Mycobiome and Bacteriome Analysis of Cystic Fibrosis Airways during Exacerbation. ( Audebert, C; Delhaes, L; Deschaght, P; Loywick, A; Merlin, S; Nguyen, LD; Van Daele, S; Vaneechoutte, M; Viscogliosi, E, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pompilio, A | 1 |
| Riviello, A | 1 |
| Crocetta, V | 1 |
| Di Giuseppe, F | 1 |
| Pomponio, S | 1 |
| Sulpizio, M | 1 |
| Di Ilio, C | 1 |
| Angelucci, S | 1 |
| Barone, L | 1 |
| Di Giulio, A | 1 |
| Di Bonaventura, G | 1 |
| Nguyen, LD | 1 |
| Deschaght, P | 1 |
| Merlin, S | 1 |
| Loywick, A | 1 |
| Audebert, C | 1 |
| Van Daele, S | 1 |
| Viscogliosi, E | 1 |
| Vaneechoutte, M | 1 |
| Delhaes, L | 1 |
| Rogers, GB | 4 |
| Stressmann, FA | 2 |
| Koller, G | 1 |
| Daniels, T | 1 |
| Carroll, MP | 4 |
| Bruce, KD | 4 |
| Marsh, P | 1 |
| Stressmann, AF | 1 |
| Allen, CE | 1 |
| Daniels, TV | 1 |
| Daniels, TW | 1 |
| van der Gast, CJ | 2 |
| Jones, GR | 1 |
| Connett, GJ | 1 |
| Legg, JP | 1 |
| Rüger, M | 1 |
| Bensch, G | 1 |
| Tüngler, R | 1 |
| Reichl, U | 1 |
| Cuthbertson, L | 1 |
| Hoffman, LR | 1 |
| Wing, PA | 1 |
| Pope, C | 1 |
| Hooftman, DA | 1 |
| Lilley, AK | 1 |
| Oliver, A | 1 |
| Cheung, KJ | 1 |
| Li, G | 1 |
| Urban, TA | 1 |
| Goldberg, JB | 1 |
| Griffith, A | 1 |
| Lu, F | 1 |
| Burns, JL | 1 |
8 other studies available for propidium and Cystic Fibrosis of Pancreas
| Article | Year |
|---|---|
Evaluation of antibacterial and antibiofilm mechanisms by usnic acid against methicillin-resistant Staphylococcus aureus.
Topics: Adhesins, Bacterial; Anti-Bacterial Agents; Bacterial Proteins; Benzofurans; Biofilms; Carrier Prote | 2016 |
Effects of Propidium Monoazide (PMA) Treatment on Mycobiome and Bacteriome Analysis of Cystic Fibrosis Airways during Exacerbation.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azides; Biodiversity; Cystic Fibrosis; Disease Progression | 2016 |
Assessing the diagnostic importance of nonviable bacterial cells in respiratory infections.
Topics: Adult; Azides; Cell Membrane Permeability; Cross-Linking Reagents; Cystic Fibrosis; DNA, Bacterial; | 2008 |
The exclusion of dead bacterial cells is essential for accurate molecular analysis of clinical samples.
Topics: Adult; Anti-Bacterial Agents; Azides; Cystic Fibrosis; DNA, Bacterial; False Positive Reactions; Gen | 2010 |
Impact of antibiotic treatment for pulmonary exacerbations on bacterial diversity in cystic fibrosis.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azides; Biodiversity; Cystic Fibrosis; Disease Progression | 2013 |
A flow cytometric method for viability assessment of Staphylococcus aureus and Burkholderia cepacia in mixed culture.
Topics: Bacterial Load; Bacteriological Techniques; Benzothiazoles; Burkholderia cepacia; Burkholderia Infec | 2012 |
Reducing bias in bacterial community analysis of lower respiratory infections.
Topics: Adult; Azides; Bacteria; Cystic Fibrosis; Humans; Propidium; Pseudomonas aeruginosa; Real-Time Polym | 2013 |
Pilus-mediated epithelial cell death in response to infection with Burkholderia cenocepacia.
Topics: Annexin A5; Apoptosis; Blotting, Western; Burkholderia cepacia complex; Burkholderia Infections; Cas | 2007 |